Why do patients with Parkinson’s disease fall? A cross-sectional analysis of possible causes of falls

npj Parkinson's Disease

Volumn 1, Issue 1, 2015, Pages

  Schrag, Anette ^a   Choudhury, Mahbuba ^a   Kaski, Diego ^a   Gallagher, David A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84984638910     PISSN: None     EISSN: 23738057     Source Type: Journal    
DOI: 10.1038/npjparkd.2015.11     Document Type: Article

References (51)

1. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. On the nature of fear of falling in Parkinson's disease. Behav Neurol 2011; 24: 219–228.
2. Varanese S, Birnbaum Z, Rossi R, Di RA. Treatment of advanced Parkinson's disease. Parkinsons Dis 2011; 2010: 480260.
3. Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA. Predictors of future falls in Parkinson disease. Neurology 2010; 75: 116–124.
4. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181–184.
5. Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol 2001; 248: 950–958.
6. Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord 2007; 22: 1892–1900.
7. Duncan RP, Earhart GM. Should one measure balance or gait to best predict falls among people with Parkinson disease? Parkinsons Dis 2012; 2012: 923493.
8. Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry 2006; 77: 468–473.
9. Latt MD, Lord SR, Morris JG, Fung VS. Clinical and physiological assessments for elucidating falls risk in Parkinson's disease. Mov Disord 2009; 24: 1280–1289.
10. Paul SS, Sherrington C, Canning CG, Fung VS, Close JC, Lord SR. The relative contribution of physical and cognitive fall risk factors in people with Parkinson's disease: a large prospective cohort study. Neurorehabil Neural Repair 2014; 28: 282–290.
11. Kim JS, Jang W, Cho JW, Ahn JY, Kim HT. Bedside cognitive assessments and falls risk in Parkinson's disease. Neurol Sci 2013; 34: 75–78.
12. Parashos SA, Wielinski CL, Giladi N, Gurevich T. National Parkinson Foundation Quality Improvement Initiative Investigators. Falls in Parkinson disease: analysis of a large cross-sectional cohort. J Parkinsons Dis 2013; 3: 515–522.
13. Romenets SR, Gagnon JF, Latreille V, Panniset M, Chouinard S, Montplaisir J et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Mov Disord 2012; 27: 996–1003.
14. Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011; 77: 1048–1054.
15. Bryant MS, Rintala DH, Hou JG, Rivas SP, Fernandez AL, Lai EC et al. The relation of falls to fatigue, depression and daytime sleepiness in Parkinson's disease. Eur Neurol 2012; 67: 326–330.
16. Gallagher DA, Parkkinen L, O'Sullivan SS, Spratt A, Shah A, Davey CC et al. Testing an aetiological model of visual hallucinations in Parkinson's disease. Brain 2011; 134: 3299–3309.
17. Goetz CG, Tilley BC, Shaftman SR. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results. Mov Disord 2008; 23: 2129–2170.
18. Marinus J, Visser M, Verwey NA, Verhey FR, Middelkoop HA, Stiggelbout AM et al. Assessment of cognition in Parkinson's disease. Neurology 2003; 61: 1222–1228.
19. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004; 19: 1306–1312.
20. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193–213.
21. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540–545.
22. American Academy of Sleep Medicine The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. American Academy of Sleep Medicine: Rochester, MN, 2001.
23. Friedberg G, Zoldan J, Weizman A, Melamed E. Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 1998; 21: 280–284.
24. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123.
25. Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 579–584.
26. Upadhyaya AK, Stanley I. Hospital anxiety depression scale. Br J Gen Pract 1993; 43: 349–350.
27. Sprague JB, Stock LA, Connett J, Bromberg J. Study of chart designs and optotypes for preschool vision screening. Comparability of chart designs. J Pediatr Ophthalmol Strabismus 1989; 26: 189–197.
28. Niederhauser S, Mojon DS. Normal Isopter Position in the Peripheral Visual Field in Goldmann Kinetic Perimetry. Ophthalmologica 2002; 216: 406–408.
29. Riddoch JM, Humphreys GW. Birmingham Object Recognition Battery. Psychology Press, 1993.
30. Mak MK, Auyeung MM. The mini-BESTest can predict parkinsonian recurrent fallers: a 6-month prospective study. J Rehabil Med 2013; 45: 565–571.
31. Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J. REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 2008; 79: 1117–1121.
32. Yarnall A, Rochester L, Burn DJ. The interplay of cholinergic function, attention, and falls in Parkinson's disease. Mov Disord 2011; 26: 2496–2503.
33. Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 2002; 72: 721–725.
34. Kempster PA, O'Sullivan SS, Holton JL, Revesz T, Lees AJ. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain 2010; 133: 1755–1762.
35. Allan LM, Ballard CG, Rowan EN, Kenny RA. Incidence and prediction of falls in dementia: a prospective study in older people. PLoS One 2009; 4: e5521.
36. Revilla FJ, Larsh TR, Mani A, Duker AP, Cox C, Succop P et al. Effect of dopaminergic medication on postural sway in advanced Parkinson's disease. Front Neurol 2013; 4: 202.
37. Grimbergen YA, Langston JW, Roos RA, Bloem BR. Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus. Expert Rev Neurother 2009; 9: 279–290.
38. Kim SD, Allen NE, Canning CG, Fung VS. Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management. CNS Drugs 2013; 27: 97–112.
39. Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G et al. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 2012; 11: 589–596.
40. Kucinski A, Paolone G, Bradshaw M, Albin RL, Sarter M. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation. J Neurosci 2013; 33: 16522–16539.
41. Kalia M. Neurobiology of sleep. Metabolism 2006; 55: S2–S6.
42. Kaufmann H, Goldstein DS. Autonomic dysfunction in Parkinson disease. Handb Clin Neurol 2013; 117: 259–278.
43. Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 2010; 75: 1263–1269.
44. Yogev-Seligmann G, Hausdorff JM, Giladi N. Do we always prioritize balance when walking? Towards an integrated model of task prioritization. Mov Disord 2012; 27: 765–770.
45. Mirelman A, Maidan I, Herman T, Deutsch JE, Giladi N, Hausdorff JM. Virtual reality for gait training: can it induce motor learning to enhance complex walking and reduce fall risk in patients with Parkinson's disease? J Gerontol A Biol Sci Med Sci 2011; 66: 234–240.
46. Robinovitch SN, Feldman F, Yang Y, Schonnop R, Leung PM, Sarraf T et al. Video capture of the circumstances of falls in elderly people residing in long-term care: an observational study. Lancet 2013; 381: 47–54.
47. Peppe A, Pierantozzi M, Baiamonte V, Moschella V, Caltagirone C, Stanzione P et al. Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. Sleep 2012; 35: 1637–1642.
48. Sauerbier A, Ray Chaudhuri K. Parkinson's disease and vision. Basal Ganglia 2013; 3: 159–163.
49. Rocha FL, Murad MG, Stumpf BP, Hara C, Fuzikawa C. Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis. J Psychopharmacol 2013; 27: 417–423.
50. Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 66: 996–1002.
51. Eng ML, Welty TE. Management of hallucinations and psychosis in Parkinson's disease. Am J Geriatr Pharmacother 2010; 8: 316–330.